Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
AssigneeUniversity of Washington through its Center for Commercialization
InventorsMichael J. Gale, Jr., Gretja Schnell, Yueh-Ming Loo
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided that enable activation of innate immune responses through RIG-I like receptor signaling. The compositions and methods incorporate synthetic nucleic acid pathogen associated molecular patterns (PAMPs) that comprise elements initially characterized in, and derived from, the hepatitis C virus genome.
Claims20
A method of inducing RLR signaling in a subject, comprising administering to the subject an effective amount of a pharmaceutical composition comprising a synthetic nucleic acid pathogen-associated molecular pattern (PAMP), wherein the synthetic PAMP comprises:
- a 5′-arm region comprising a terminal triphosphate;
- a poly-uracil core comprising at least 8 contiguous uracil residues;
- and
- a 3′-arm region comprising at least 8 nucleic acid residues, wherein the 5′-most nucleic acid residue of the 3′-arm region is not a uracil and wherein the 3′-arm region is at least 80% uracil residues.
Dependencies are inferred from the claim text.